SCHEMBL4418141

SCHEMBL4418141

CCOC(=O)C(C)(C(C)=O)C1CC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.38
LMNA P02545 1/20 0.38
HSD17B10 Q99714 1/20 0.38
PKM P14618 3/20 0.38
KDM4E B2RXH2 1/20 0.38
CYP4F2 P78329 3/20 0.37
CYP4A11 Q02928 3/20 0.37
THRB P10828 1/20 0.37
HTT P42858 1/20 0.36
PPM1B O75688 1/20 0.35
PTPN1 P18031 1/20 0.35
PPP1CC P36873 1/20 0.35
MMP8 P22894 1/20 0.35
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
MAPT P10636 2/20 0.33
ATM Q13315 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
ABCB11 O95342 1/20 0.33
CYP1A2 P05177 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15973848 0.93 PKM (0.36) ALDH1A1LMNAHSD17B10PKMKDM4E
SCHEMBL15973183 0.91 ALDH1A1 (0.38) ALDH1A1LMNAHSD17B10PKMKDM4E
SCHEMBL9219742 0.90 CYP4F2 (0.40) ALDH1A1LMNAHSD17B10PKMKDM4E
SCHEMBL10708309 0.83 CYP4F2 (0.36) ALDH1A1LMNAPKMKDM4ECYP4F2
SCHEMBL10028034 0.82 ALDH1A1 (0.39) ALDH1A1PKMKDM4ECYP4F2CYP4A11
SCHEMBL10486329 0.82 CYP4F2 (0.38) ALDH1A1LMNAHSD17B10PKMKDM4E
SCHEMBL20565137 0.81 NFKB1 (0.38) ALDH1A1PKMKDM4ECYP4F2CYP4A11
SCHEMBL16732122 0.81 ALDH1A1 (0.41) ALDH1A1KDM4ECYP4F2CYP4A11THRB
SCHEMBL15910254 0.78 CYP4F2 (0.39) PKMCYP4F2CYP4A11THRBHTT
SCHEMBL11017860 0.76 CYP1A2 (0.42) ALDH1A1LMNAPKMCYP4F2CYP4A11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1461337-B1 PYRIDO¬2,1-A ISOQUINOLINE DERIVATIVES AS DPP-IV INHIBITORS HOFFMANN LA ROCHE (CH) 2009-10-14 EP disclosed
US-6897222-B2 Pyrido[2,1-a]isoquinoline derivatives HOFFMANN-LA ROCHE INC. (US) 2005-05-24 US disclosed
EP-1461337-A1 PYRIDO[2,1-A]ISOQUINOLINE DERIVATIVES AS DPP-IV INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2004-09-29 EP disclosed
US-20040176406-A1 Pyrido [2,1-a] isoquinoline derivatives GOBBI LUCA CLAUDIO (CH) 2004-09-09 US disclosed
US-6727261-B2 BENZO(A)QUINOLIZINE DERIVATIVES FOR DIABETES AND NON-ISULIN DEPENDENT DIABETES TREATMENT HOFFMAN-LA ROCHE INC. 2004-04-27 US disclosed
US-20030149071-A1 Pyrido [2,1-a] isoquinoline derivatives HOFFMANN-LA ROCHE INC. 2003-08-07 US disclosed
WO-2003055881-A1 PYRIDO(2,1-A)ISOQUINOLINE DERIVATIVES AS DPP-IV INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2003-07-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030149071-A1 Pyrido [2,1-a] isoquinoline derivatives DPP4, DPP7, DPP3 ALDH1A1 84/4885LMNA 4651/4885HSD17B10 1095/4885
US-20040176406-A1 Pyrido [2,1-a] isoquinoline derivatives DPP4, DPP7, DPP3 ALDH1A1 84/4885LMNA 4651/4885HSD17B10 1095/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.